Onconova Therapeutics, Inc. Recorded Big Gain

Onconova Therapeutics, Inc. (ONTX:NASDAQ) soared at $1.09, a gain of 53.5%. On Fri, Apr 21, 2023, ONTX:NASDAQ hit a New 2-Week High of $1.09. The stock appeared on our News Catalysts scanner on Wed, Apr 19, 2023 at 09:38 AM in the 'BIOTECH' category. From Mon, Apr 10, 2023, the stock recorded 44.44% Up Days and 50.00% Green Days
About Onconova Therapeutics, Inc. (ONTX:NASDAQ)
Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule drug candidates to treat cancer. The Company has three clinical-stage product candidates and six preclinical programs.
Top 10 Gainers:
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 219.15%
- Mangoceuticals Inc. (MGRX:NASDAQ), 60.87%
- EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ), 58.45%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 53.52%
- Presto Automation Inc Com (PRST:NASDAQ), 36.23%
- CBL International Limited (BANL:NASDAQ), 34.75%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 24.47%
- SRAX, Inc. (SRAX:NASDAQ), 24.39%
- Icosavax Inc. (ICVX:NASDAQ), 23.82%
- Tenaya Therapeutics Inc. (TNYA:NASDAQ), 22.79%